NewAge Announces New Anti-Aging Discovery and Filing of Patent on New Formula
November 16 2021 - 6:00AM
NewAge, Inc. (Nasdaq: NBEV), the
Colorado-based direct-to-consumer (D2C) organic and healthy
products company, today announced the discovery of a new method of
action to fight the effects of aging and the filing of a new patent
to protect the uniqueness of the discovery.
Following publication in the Journal of
Biosciences and Medicine of the recent discovery on how to block
spike proteins from binding to human cells, NewAge scientists have
filed for a patent that contains multiple unique claims, and a new
discovery that supports cardiovascular health and anti-aging. The
new discovery encapsulated in the patent includes a powerful new
way to unblock the secretion signal from the hypothalamus, thereby
stimulating the anterior pituitary gland to naturally secrete human
growth hormone (HGH).
One of the major contributors to aging and the
decline in cardiovascular health is the increase in the production
of dipeptidyl-peptidase 4 (DPP4). DPP4 acts a signal to the
anterior pituitary and it degrades over time as humans biologically
age. With a new combination of natural ingredients including
Tahitian NONI® fruit and pterostilbene, NewAge scientists have
developed a method of action to unblock the DPP4 signal by 99.1%
and allow the secretion from the hypothalamus to the anterior
pituitary, thereby triggering the body to naturally regulate itself
and secrete growth hormone, as it did when the body was in growth
and development mode versus in the aging process.
“The filing of this patent and unveiling of this
unique discovery is an incredible achievement in both science and
technology to help people take control of the aging process and age
healthy,” said Brett West, NewAge’s Senior Director of Research.
“This is the first product to simultaneously address specific
multiple pathways by which Human Growth Hormone declines in the
body. The results from our laboratory studies and trials represent
real scientific breakthrough with globally relevant applications,
and we are incredibly proud of the team that contributed to the
discovery.”
In addition to unblocking the hypothalamus
secretion signal, NewAge scientists have leveraged a mechanism to
suppress somatostatin release and stimulate the anterior pituitary
gland, a major organ of the body’s endocrine system that affects
growth, hormone production, and regulation. Growth hormone is
essential during childhood development and continues to help
maintain tissue and organ health throughout one’s lifetime. As a
person ages, however, the amount of HGH produced slows
dramatically. This decline is due in part to both a reduction in
GH-releasing hormone (GHRH) and an increase in somatostatin, also
known as a GH-inhibiting hormone (GHIH). In addition, an enzyme
produced in the body — dipeptidyl-peptidase 4 (DPP4) — also works
to inhibit GHRH, thereby contributing to further decline resulting
in lower energy levels, reduced muscle mass, weight gain, and a
variety of other age-related changes. NewAge has discovered a
natural way to simultaneously inhibit DPP4 and decrease
somatostatin.
Deanna Latson, NewAge’s Chief Product Officer,
commented, “This is the first time that scientists have ascertained
how to simultaneously address these specific pathways by which HGH
declines in the body. As a result, we can now trigger the body’s
natural regeneration process and support cellular health. No other
product to our knowledge can improve cell regeneration, inhibit
cellular apoptosis, support physical resilience, boost energy and
stamina, and combat other adverse effects of aging.”
Ms. Latson continued, “Because of the positive
impact on health, people notice a change in the elasticity of their
skin, the color in their cheeks, and increased energy levels. We
couldn’t even keep the samples in stock amongst the management team
during the trials. We love the fact that the product is all
natural, efficacious, and not a pharmaceutical drug – it’s better.
Heart Disease is the number one cause of death in the world, and we
now believe we can make major strides in making a difference for
consumers as we bring these new discoveries to the world.”
Statements or claims in this document have not
been evaluated by the Food and Drug Administration.
About NewAge, Inc.
NewAge is a purpose-driven firm dedicated to
inspiring the planet to Live Healthy™. Colorado-based NewAge
commercializes a portfolio of organic and healthy products
worldwide through primarily a direct-to-consumer (D2C) route to
market distribution system across more than 50 countries. The
company competes in three major category platforms including health
and wellness, inner and outer beauty, and nutritional performance
and weight management — through a network of exclusive independent
Brand Partners, empowered with the leading social selling tools and
technology available worldwide. More information on the Company can
be found at NewAgeGroup.com.
Contact:
InvestorsNewAge, Inc.Lisa MuellerVP, Investor
Relationsir@newage.com
NewAge (NASDAQ:NBEV)
Historical Stock Chart
From Mar 2024 to Apr 2024
NewAge (NASDAQ:NBEV)
Historical Stock Chart
From Apr 2023 to Apr 2024